OUTLOOK THERAPEUTICS, INC. (OTLK) Gross Margin
- Gross margin · 12 months: Value (m); Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | (m) | Gross profit / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | -2.28M USD | Gross Profit |
| Revenue | (m) | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 1.11M USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $-2.28M | (m) | $1.11M | (m) |
| 2026-03-31 | $-1.20M | (m) | $1.54M | (m) |
| 2025-12-31 | (m) | (m) | (m) | (m) |
| 2025-09-30 | $57.20K | $1.41M | $1.36M | 4.05% |
| 2025-06-30 | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | $8.15M | (m) | (m) |
| 2019-06-30 | (m) | $3.06M | (m) | (m) |
| 2019-03-31 | (m) | $3.25M | (m) | (m) |
| 2018-12-31 | (m) | $3.38M | (m) | (m) |
| 2018-09-30 | (m) | $3.09M | (m) | (m) |
| 2018-06-30 | (m) | $5.22M | (m) | (m) |
| 2018-03-31 | (m) | $4.75M | (m) | (m) |
| 2017-12-31 | (m) | $4.28M | (m) | (m) |
| 2017-09-30 | (m) | $3.81M | (m) | (m) |
| 2017-06-30 | (m) | $1.40M | (m) | (m) |
| 2017-03-31 | (m) | $1.60M | (m) | (m) |
| 2016-12-31 | (m) | $2.29M | (m) | (m) |
| 2016-09-30 | (m) | $2.98M | (m) | (m) |
| 2016-06-30 | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | (m) | (m) | (m) |
| 2015-09-30 | (m) | $5.22M | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |